<?xml version="1.0" encoding="UTF-8"?>
<p id="p0135">As a matter of fact, as with epidemics that have occurred before and since the death ratio caused by COVID 19 is quite high, mitigation methods need to be developed, one of which is through the development of vaccines that have not yet been found. Specific vaccines could be used to initiate the formation of specific antibodies against the SARS-CoV2 virus. This development is being temporarily developed in various parts of the world and is the focus of todayâ€™s global efforts. In fact, according to a news release from Jakarta Globe on March 27, 2019, the G20 has set aside about USD$ 4 billion for the development of the vaccine [
 <xref rid="bib40" ref-type="bibr">40</xref>,
 <xref rid="bib43" ref-type="bibr">43</xref>].
</p>
